EUVIMEDEUVIMED entdecken
Open Access

Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4 + T cells through regulating type 2 conventional dendritic cells

Jing Luo, Shuju Pang, Zhenzhen Hui, Hua Zhao, Shilei Xu, Wenwen Yu, Lili Yang, Qian Sun, Xishan Hao, Feng Wei, Jian Wang, Xiubao Ren

Theranostics · 2023

DOI: 10.7150/thno.86792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Jing Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesNeoplasmsMiceHumansAnimalsHepatitis A Virus Cellular Receptor 2ImmunotherapyDendritic CellsCD4-Positive T-LymphocytesTumor MicroenvironmentNucleotides, Cyclic

Stichwörter der Autor:innen

ADU-S100Cancer immunotherapyDCSTINGTim-3

Substanzen

Hepatitis A Virus Cellular Receptor 2ADU-S100Nucleotides, Cyclic

Autor:innen und Institutionen

  • Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.
  • Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
  • Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, 300060, China.
  • Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
  • Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
  • Haihe Laboratory of Cell Ecosystem, Tianjin 300060, China.

Zitieren

APA

Luo, J., Pang, S., Hui, Z., Zhao, H., Xu, S., Yu, W., Yang, L., Sun, Q., Hao, X., Wei, F., Wang, J., & Ren, X. (2023). Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4 + T cells through regulating type 2 conventional dendritic cells. Theranostics. https://doi.org/10.7150/thno.86792

Vancouver

Luo J, Pang S, Hui Z, Zhao H, Xu S, Yu W, et al. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4 + T cells through regulating type 2 conventional dendritic cells. Theranostics. 2023. doi:10.7150/thno.86792

BibTeX
@article{Luo2023,
  author = {Luo, Jing and Pang, Shuju and Hui, Zhenzhen and Zhao, Hua and Xu, Shilei and Yu, Wenwen and Yang, Lili and Sun, Qian and Hao, Xishan and Wei, Feng and Wang, Jian and Ren, Xiubao},
  title = {Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4 + T cells through regulating type 2 conventional dendritic cells},
  journal = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.86792}
}
Kostenlos starten →